Among patients prescribed semaglutide, researchers found a 58% reduction in the risk of death from opioid overdoses compared to those on older diabetes medications.
The study suggests that the drug may alter users' cravings for opioids and other substances, but the exact mechanisms are still not well understood.
These findings, not funded by the drugmaker, contribute to the growing list of health benefits associated with GLP-1 medications beyond weight loss.
While the exact relationship between semaglutide and reduced opioid overdose deaths remains unclear, it raises important questions about addiction treatment and management.
Collection
[
|
...
]